Gå direkt till huvudinnehållet

Levermetastaser

Senast reviderad:
Sakkunnig:
Definition:
Spridning av maligna tumörer till levern, oftast från kolorektalcancer.
Förekomst:
Den vanligaste formen av cancer i levern.
Symtom:
Länge utan symtom. Efter hand förekommer trötthet, sjukdomskänsla, dåligt allmäntillstånd, tyngdkänsla i buken och frossa.
Fynd:
Kan bestå av ikterus, stor och knottrig lever, ascites, eventuellt lymfadenopati.
Diagnostik:
Provtagning bidrar sällan till diagnosen, bilddiagnostik (ultraljud, CT, MR) och biopsi behövs för diagnosen.
Behandling:
Kurativ eller palliativ behandling, beroende på cancersjukdomens stadium och histologi.
  1. Schmoll HJ, Van CE, Stein A, et al.: ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol 2012; 23:2479-2516. PubMed  
  2. Venook AP, Curley SA. Management of potentially resectable colorectal cancer liver metastases. UpToDate, last updated Aug 13, 2015. UpToDate  
  3. Bjørnbeth BA. Behandling av levermetastaser fra koloncancer. Kirurgen.no, publisert 14. april 2014 . kirurgen.no  
  4. Knowles B, Welsh FKS, Rees M, et al.: Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy. HPB 2012, 14(5): 298-309
  5. Sahani DV, Bajwa MA, Andrabi Y, Bajpai S, Cusack JC. Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma. Ann Surg. 2014 May. 259(5):861-72.
  6. Xia Q, Liu J, Wu C, et al. Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis. Cancer Imaging. 2015. pmid:26589835 PubMed  
  7. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).. Ann Surg 2004; 240: 438-50. PubMed  
  8. Berri RN, Abdalla EK. Curable metastatic colorectal cancer: recommended paradigms. Curr Oncol Rep 2009; 11:200. PubMed  
  9. Adam R, de Haas RJ, Wicherts DA, et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 2008; 26:3672. PubMed  
  10. DeMatteo RP, Palese C, Jarnagin WR et al. Anatomical segmental hepatic resection is superior to wedge resection as an oncological operation for colorectal liver metastasis. J Gastrointest Surg 2000; 4: 178-84. PubMed  
  11. Nagakura S, Shirai Y, Yokoyama N et al. Major hepatic resection reduces the probability of intrahepatic recurrences following resection of colorectal carcinoma liver metastasis. Hepatogastroenterology 2003; 50: 779-83. PubMed  
  12. Morris EJ, Forman D, Thomas JD, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010; 97:1110. PubMed  
  13. Baden H, Andersen B. Survival of patients with untreated liver metastases from colorectal cancer. Scand J Gastroenterol 1975; 10: 221-3. PubMed  
  14. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 1999; 230: 309-21. PubMed  
  • Remy Waardenburg, specialist i allmänmedicin, medicinsk redaktör Medibas

Tidigare sakkunniga

  • Hanns-Ulrich Marschall, professor och överläkare, Medicinkliniken gastrosektionen, Sahlgrenska universitetssjukhuset, Göteborg